Shares of Axon Enterprise, Inc. (NASDAQ:AXON – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the fourteen ratings firms that are currently covering the company, Marketbeat reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have issued a buy rating on the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $604.67.
AXON has been the topic of a number of analyst reports. The Goldman Sachs Group increased their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research note on Monday, January 27th. JMP Securities reaffirmed an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Craig Hallum cut shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a research note on Monday, March 10th. Needham & Company LLC restated a “buy” rating and set a $600.00 target price on shares of Axon Enterprise in a research note on Wednesday, February 26th. Finally, Northcoast Research lowered Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th.
View Our Latest Research Report on Axon Enterprise
Insiders Place Their Bets
Institutional Trading of Axon Enterprise
Several institutional investors have recently modified their holdings of AXON. Fourth Dimension Wealth LLC acquired a new position in Axon Enterprise during the 4th quarter worth about $30,000. New Wave Wealth Advisors LLC bought a new position in Axon Enterprise during the fourth quarter worth $40,000. Y.D. More Investments Ltd acquired a new position in Axon Enterprise in the fourth quarter valued at $45,000. Elequin Capital LP bought a new stake in Axon Enterprise during the fourth quarter valued at $46,000. Finally, Prestige Wealth Management Group LLC grew its holdings in Axon Enterprise by 115.8% during the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after acquiring an additional 44 shares during the period. Institutional investors own 79.08% of the company’s stock.
Axon Enterprise Stock Performance
Shares of NASDAQ:AXON opened at $559.84 on Thursday. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The firm has a market cap of $42.90 billion, a PE ratio of 144.66, a PEG ratio of 5.17 and a beta of 1.13. The company’s 50 day moving average price is $571.11 and its two-hundred day moving average price is $558.24. Axon Enterprise has a 12-month low of $273.52 and a 12-month high of $715.99.
Axon Enterprise Company Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Read More
- Five stocks we like better than Axon Enterprise
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Quantum Computing: The $6.5 Billion Opportunity You Can’t Ignore
- What is a Stock Market Index and How Do You Use Them?
- Are Tariffs Threatening Disney’s Comeback Story?
- What is the S&P/TSX Index?
- Is Alphabet a Generational Buying Opportunity at These Levels?
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.